Risk of Atypical Femoral Fracture during and after Bisphosphonate Use

  • Schilcher J
  • Koeppen V
  • Aspenberg P
  • et al.
129Citations
Citations of this article
33Readers
Mendeley users who have this article in their library.
Get full text

Abstract

This letter indicates that there is long-lasting skeletal accumulation of bisphosphonate, and ongoing use appears to be the dominant risk factor for rare fractures.

Cite

CITATION STYLE

APA

Schilcher, J., Koeppen, V., Aspenberg, P., & Michaëlsson, K. (2014). Risk of Atypical Femoral Fracture during and after Bisphosphonate Use. New England Journal of Medicine, 371(10), 974–976. https://doi.org/10.1056/nejmc1403799

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free